Substituted pyridines, and use thereof as GSK3 inhibitors

US8664246B2 · kind B2 · utility

Assignee

• Bayer Intellectual Property GmbH · DE

Inventors

• Stephan Siegel · Berlin, DE
• Andreas Wilmen
• Niels Svenstrup · Copenhagen, DK
• Mark Jean Gnoth · Mettmann, DE
• Adrian Tersteegen · Wuppertal, DE
• Ulrich Rester · Wuppertal, DE

Key dates

• Filing date: Jul 21, 2009
• Grant date: Mar 4, 2014
• Expiry date: Oct 9, 2029

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D401/12
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to substituted pyridines and to processes for preparation thereof, and to the use thereof for production of medicaments for treatment and/or prophylaxis of diseases, especially of haematological disorders, preferably of leukopenia and neutropenia.